Indeferimento
#9.2
11/19/2024
RPI 2811
Application data
Number
112018074990Type
Filing
Publication
PCT
US2017035991 The application was refused by the INPI on 11/19/2024. The invention was never patented.
Talk to a specialistLatest action published by the INPI: 11/19/2024. We update with every new RPI gazette, published weekly.
Applicants
BEYONDSPRING PHARMACEUTICALS, INC.
US
Inventors
G. L. (pessoa física)
US
L. H. (pessoa física)
US
R. M. (pessoa física)
US
IPC Classification
Priority claims
US
62/346,426 · 06/06/2016
US
62/454,628 · 02/03/2017
Abstract
São aqui divulgados métodos para reduzir neutropenia que é causada por quimioterapia ou terapia de radiação administrando plinabulina a um sujeito.
Publications in the Brazilian Industrial Property Gazette (RPI).
#9.2
11/19/2024
RPI 2811
#7.1
06/04/2024
RPI 2787
#6.23
10/19/2021
RPI 2650
#15.35
09/21/2021
RPI 2646
#1.3
03/12/2019
RPI 2514
#1.1
12/11/2018
RPI 2501
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.